CIK: 0001400240 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 15, 2018
Total Value ($000): $344,896 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNLI | DENALI THERAPEUTICS INC | 8,918,749 | $175,610 | 50.9% | $17.97 | +14.4% | COM | 24823R105 |
| — | SERES THERAPEUTICS INC | 12,682,876 | $93,092 | 27.0% | $12.29 | — | COM | 81750R102 |
| — | SYROS PHARMACEUTICALS INC | 3,204,437 | $41,594 | 12.1% | $13.87 | — | COM | 87184Q107 |
| QTRX | QUANTERIX CORP | 2,030,495 | $34,600 | 10.0% | $19.52 | +2.7% | COM | 74766Q101 |